Albany Molecular Research (AMRI) Stock: Gaining On Takeover Chatter

Albany Molecular Research, Inc. (NASDAQ: AMRI) is climbing like a rocket as I write this, and for good reason. There’s chatter surfacing that’s suggesting that the company will soon be taken over. Of course, this is leading to excitement among investors, causing the gains and prompting our partners at Trade Ideas to alert us to the movement. At the moment (1:56), AMRI is trading at $22.17 per share after a gain of $2.00 per share or 9.92% thus far today.

AMRI Gains On Takeover Chatter

As mentioned above, Albany Molecular Research is off to an incredibly climb in the market at the moment as takeover chatter swarms the market. At the moment, the chatter is nothing more than rumors, and vague rumors at that. There’s no insinuation of who the possible suitor might be, nor the price of the potential takeover.

As mentioned in various articles like this in the past, chasing takeover rumors can be a dangerous game. While we see these types of rumors often in the market, very few of them ever prove to be valid. So, if you’re going to trade on this rumor, please make sure you do so with caution.

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on AMRI. In particular, we’re interested in learning if there is any validity to the takeover rumors. Of course, if a takeover did happen, it would likely lead to a strong return of value for shareholders. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required

Leave a Comment